Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124

Study identifier:CIN-107-130

ClinicalTrials.gov identifier:NCT05459688

EudraCT identifier:N/A

CTIS identifier:N/A

Recruitment Complete

Official Title

An Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124 to Evaluate the Long-Term Safety and Effectiveness of CIN-107

Medical condition

hypertension

Phase

Phase 2

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

175

Study type

Interventional

Age

18 Years - 100 Years

Date

Study Start Date: 06 Apr 2022
Estimated Primary Completion Date: 22 Nov 2023
Estimated Study Completion Date: 22 Nov 2023

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: -
Primary Purpose: Treatment

Verification:

Verified 01 Jun 2023 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria